The global artificial intelligence in the diagnostic market is expected to see exponential growth in the next few years, reaching $16.24 billion in 2028 at a CAGR of 39.5%. This growth can be attributed to personalized medicine trends, increased healthcare data, global health challenges, and investments in AI technology. Major trends include collaboration and investment, advancements in technology, data privacy and security concerns, and the rise of explainable AI. The top companies in the market include Google, Microsoft, Intel, IBM, Siemens Healthineers, and GE Healthcare Technologies. Some examples of AI applications in diagnostics include HeartFlow’s AI-powered cardiac imaging, Imagen Technologies’ AI-based cancer detection, and Zebra Medical Vision’s AI algorithms for medical imaging analysis. The report also highlights the potential for AI to improve healthcare outcomes and reduce costs.